-
Mashup Score: 5JACC: CardioOncology: Vol 5, No 5 - 19 day(s) ago
J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 553–569. Cooper Quartermaine, Daniel Addison, et. al. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 570–590. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 591–609. Alexander C. Fanaroff and Lova L. Sun J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 610–612. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 613–624. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 625–627. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 628–637. Eman R. Rashed and Kenneth B. Margulies J Am
Source: www.jacc.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 9Achieving early detection and diagnosis for cardiovascular disease: A manifesto for change - 2 month(s) ago
Global Heart Hub – Manifesto
Source: globalhearthub.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Medscape Cardiologist Lifestyle & Happiness Report 2024: The Ongoing Struggle for Balance - 2 month(s) ago
Cardiologists reveal how they strive for work-life balance, mental health, and family time in their demanding profession. Their diet, exercise, drinking, and online habits are included.
Source: www.medscape.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 2Sleep Apnea a Risk Factor For Heart Failure From Cancer Therapy - American College of Cardiology - 3 month(s) ago
Sleep apnea is prevalent among patients at higher risk for developing congestive heart failure (CHF) following cancer treatment and could be used as a risk factor to identify patients who would benefit from earlier treatment, according to a study being presented at ACC’s Advancing the Cardiovascular Care of the Oncology Patient course. Obstructive sleep apnea (OSA), the focus of this study, has a prevalence of 48-52% among patients with CHF in the general population. To determine the prevalence of OSA in
Source: www.acc.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 7
The objective of this study was to identify Brazil’s most critical garbage codes (GCs) reclassified to Chagas disease (ChD) in mortality data and thei…
Source: www.sciencedirect.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 2JACC: CardioOncology: Vol 5, No 5 - 7 month(s) ago
J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 553–569. Cooper Quartermaine, Daniel Addison, et. al. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 570–590. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 591–609. Alexander C. Fanaroff and Lova L. Sun J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 610–612. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 613–624. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 625–627. J Am Coll Cardiol CardioOnc. 2023 Oct, 5 (5) 628–637. Eman R. Rashed and Kenneth B. Margulies J Am
Source: www.jacc.orgCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 0Cardio-Oncologia: prevenir e reduzir os riscos da cardiotoxicidade do tratamento e manejo das complicações cardiovasculares no paciente oncológico | Socesp - 10 month(s) ago
Mídia sobre Cardio-Oncologia: prevenir e reduzir os riscos da cardiotoxicidade do tratamento e manejo das complicações cardiovasculares no paciente oncológico
Source: socesp.org.brCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 6ESC Guidelines - Cancer treatments & cardiovascular toxicity (2016 ESC Position Paper) - 2 year(s) ago
ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Cancer treatments & cardiovascular toxicity. They should be essential in everyday clinical decision making.
Source: www.escardio.orgCategories: Cardiologists, Latest HeadlinesTweet-
RT @md_arianemacedo: Congrats !!! Outstanding work ! Avaliable at https://t.co/gipYY7vr7i #ESCCongress https://t.co/3GLp4pi4Ja
-
JACC: CardioOncology: Vol 5, No 5 https://t.co/lceNkNFIoK